1. Blonigen BJ, Steinmetz RD, Levin L, Lamba MA, Warnick RE, Breneman JC. Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery. Int J Radiat Oncol Biol Phys. 77:996–1001. 2010.
Article
2. Chin LS, Ma L, DiBiase S. Radiation necrosis following gamma knife surgery: a case-controlled comparison of treatment parameters and long-term clinical follow up. J Neurosurg. 94:899–904. 2001.
Article
3. Cho YH, Lee JM, Lee D, Park JH, Yoon K, Kim SO, et al. Experiences on two different stereotactic radiosurgery modalities of Gamma Knife and Cyberknife in treating brain metastases. Acta neurochir (Wien). 157:2003–2009. discussion 2009. 2015.
Article
4. Fahrig A, Ganslandt O, Lambrecht U, Grabenbauer G, Kleinert G, Sauer R, et al. Hypofractionated stereotactic radiotherapy for brain metastases--results from three different dose concepts. Strahlenther Onkol. 183:625–630. 2007.
Article
5. Feuvret L, Vinchon S, Martin V, Lamproglou I, Halley A, Calugaru V, et al. Stereotactic radiotherapy for large solitary brain metastases. Cancer Radiother. 18:97–106. 2014.
Article
6. Gevaert T, Levivier M, Lacornerie T, Verellen D, Engels B, Reynaert N, et al. Dosimetric comparison of different treatment modalities for stereotactic radiosurgery of arteriovenous malformations and acoustic neuromas. Radiother Oncol. 106:192–197. 2013.
Article
7. Giubilei C, Ingrosso G, D'Andrea M, Benassi M, Santoni R. Hypofractionated stereotactic radiotherapy in combination with whole brain radiotherapy for brain metastases. J Neurooncol. 91:207–212. 2009.
Article
8. Jiang XS, Xiao JP, Zhang Y, Xu YJ, Li XP, Chen XJ, et al. Hypofractionated stereotactic radiotherapy for brain metastases larger than three centimeters. Radiat Oncol. 7:36. 2012.
Article
9. Kaul D, Badakhshi H, Gevaert T, Pasemann D, Budach V, Tuleasca C, et al. Dosimetric comparison of different treatment modalities for stereotactic radiosurgery of meningioma. Acta Neurochir (Wien). 157:559–563. discussion 563-564. 2015.
Article
10. Kim YJ, Cho KH, Kim JY, Lim YK, Min HS, Lee SH, et al. Single-dose versus fractionated stereotactic radiotherapy for brain metastases. Int J Radiat Oncol Biol Phys. 81:483–489. 2011.
Article
11. Korytko T, Radivoyevitch T, Colussi V, Wessels BW, Pillai K, Maciunas RJ, et al. 12 Gy gamma knife radiosurgical volume is a predictor for radiation necrosis in non-AVM intracranial tumors. Int J Radiat Oncol Biol Phys. 64:419–424. 2006.
Article
12. Kwon AK, Dibiase SJ, Wang B, Hughes SL, Milcarek B, Zhu Y. Hypofractionated stereotactic radiotherapy for the treatment of brain metastases. Cancer. 115:890–898. 2009.
Article
13. Ma L, Sahgal A, Descovich M, Cho YB, Chuang C, Huang K, et al. Equivalence in dose fall-off for isocentric and nonisocentric intracranial treatment modalities and its impact on dose fractionation schemes. Int J Radiat Oncol Biol Phys. 76:943–948. 2010.
Article
14. Massager N, Maris C, Nissim O, Devriendt D, Salmon I, Levivier M. Experimental analysis of radiation dose distribution in radiosurgery. II. Dose fall-off outside the target volume. Stereotact Funct Neurosurg. 87:137–142. 2009.
Article
15. Meeks SL, Buatti JM, Bova FJ, Friedman WA, Mendenhall WM. Treatment planning optimization for linear accelerator radiosurgery. Int J Radiat Oncol Biol Phys. 41:183–197. 1998.
Article
16. Minniti G, Clarke E, Lanzetta G, Osti MF, Trasimeni G, Bozzao A, et al. Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis. Radiat Oncol. 6:48. 2011.
Article
17. Minniti G, D'Angelillo RM, Scaringi C, Trodella LE, Clarke E, Matteucci P, et al. Fractionated stereotactic radiosurgery for patients with brain metastases. J Neurooncol. 117:295–301. 2014.
Article
18. Murai T, Ogino H, Manabe Y, Iwabuchi M, Okumura T, Matsushita Y, et al. Fractionated stereotactic radiotherapy using CyberKnife for the treatment of large brain metastases: a dose escalation study. Clin Oncol (R Coll Radiol). 26:151–158. 2014.
Article
19. Paddick I, Lippitz B. A simple dose gradient measurement tool to complement the conformity index. J Neurosurg. 105 Suppl:194–201. 2006.
Article
20. Sio TT, Jang S, Lee SW, Curran B, Pyakuryal AP, Sternick ES. Comparing Gamma Knife and CyberKnife in patients with brain metastases. J Appl Clin Med Phys. 15:4095. 2014.
Article
21. Solberg TD, Balter JM, Benedict SH, Fraass BA, Kavanagh B, Miyamoto C, et al. Quality and safety considerations in stereotactic radiosurgery and stereotactic body radiation therapy: executive summary. Pract Radiat Oncol. 2:2–9. 2012.
Article
22. Wagner TH, Bova FJ, Friedman WA, Buatti JM, Bouchet LG, Meeks SL. A simple and reliable index for scoring rival stereotactic radiosurgery plans. Int J Radiat Oncol Biol Phys. 57:1141–1149. 2003.
Article
23. Wowra B, Muacevic A, Tonn JC. Quality of radiosurgery for single brain metastases with respect to treatment technology: a matched-pair analysis. J Neurooncol. 94:69–77. 2009.
Article
24. Yu C, Jozsef G, Apuzzo ML, Petrovich Z. Dosimetric comparison of CyberKnife with other radiosurgical modalities for an ellipsoidal target. Neurosurgery. 53:1155–1162. discussion 1162-1163. 2003.
Article
25. Zeverino M, Jaccard M, Patin D, Ryckx N, Marguet M, Tuleasca C, et al. Commissioning of the leksell Gamma Knife® Icon™. Med Phys. 44:355–363. 2017.